作者
马 榕
文章摘要
结直肠癌(CRC)是世界上三大常见癌症之一,也是相关癌症性死亡的第二大原因[1]。我国结直肠癌的发病率和死亡率也均呈上升趋势。氨酰基tRNA合成酶(ARSs)是所有细胞中蛋白质生物合成所必需的酶,它可以催化氨基酸与其同源转移RNA的连接反应[2]。目前有研究证明了ARSs通过非经典作用在结直肠癌的发生发展中起促进作用,且有相对应的靶向药物治疗。因此,研究并了解氨酰tRNA合成酶非经典作用在结直肠癌中的研究进展是必要的。
文章关键词
氨酰基tRNA合成酶;结直肠癌
参考文献
[1] BAIDOUN F,ELSHIWY K,ELKERAIE Y,et al.Colorectal Cancer Epidemiology:Recent Trends and Impact on Outcomes[J].Current drug targets,2021,22(9):998-1009.
[2] YU Y C,HAN J M,KIM S.Aminoacyl-tRNA synthetases and amino acid signaling[J].Biochimica et biophysica acta Molecular cell research,2021,1868(1):118889.
[3] WUSIMAN W,ZHANG Z,DING Q,et al.The pathophyiological role of aminoacyl-tRNA synthetases in digestive system diseases[J].Frontiers in physiology,2022,13:935576.
[4] KIM D G,CHOI J W,LEE J Y,et al.Interaction of two translational components,lysyl-tRNA synthetase and p40/37LRP,in plasma membrane promotes laminin-dependent cell migration[J].FASEB journal: official publication of the Federation of American Societies for Experimental Biology,2012,26(10):4142-59.
[5] KIM S B,KIM H R,PARK M C,et al.Caspase-8 controls the secretion of inflammatory lysyl-tRNA synthetase in exosomes from cancer cells[J].The Journal of cell biology,2017,216(7):2201-16.
[6] SUH J H,PARK M C,GOUGHNOUR P C,et al.Plasma Lysyl-tRNA Synthetase 1(KARS1)as a Novel Diagnostic and Monitoring Biomarker for Colorectal Cancer[J].Journal of clinical medicine,2020,9(2).
[7] BONFILS G,JAQUENOUD M,BONTRON S,et al.Leucyl-tRNA synthetase controls TORC1 via the EGO complex[J].Molecular cell,2012,46(1):105-10.
[8] YOON S,KIM J H,YOON I,et al.Discovery of(S)-4-isobutyloxazolidin-2-one as a novel leucyl-tRNA synthetase(LRS)-targeted mTORC1 inhibitor[J].Bioorganic&medicinal chemistry letters,2016,26(13):3038-41.
[9] KIM J H,LEE C,LEE M,et al.Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction[J].Nature communications,2017,8(1):732.
[10] OTANI A,SLIKE B M,DORRELL M I,et al.A fragment of human TrpRS as a potent antagonist of ocular angiogenesis[J].Proceedings of the National Academy of Sciences of the United States of America,2002,99(1):178-83.
[11] WAKASUGI K,SLIKE B M,HOOD J,et al.A human aminoacyl-tRNA synthetase as a regulator of angiogenesis[J].Proceedings of the National Academy of Sciences of the United States of America,2002,99(1):173-7.
[12] ZHOU Q,KIOSSES W B,LIU J,et al.Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine[J].Methods(San Diego,Calif),2008,44(2):190-5.
[13] RAHMAN-ROBLICK R,ROBLICK U J,HELLMAN U,et al.p53 targets identified by protein expression profiling[J].Proceedings of the National Academy of Sciences of the United States of America,2007,104(13):5401-6.
[14] TAKAHASHI Y,BUCANA C D,CLEARY K R,et al.p53,vessel count,and vascular endothelial growth factor expression in human colon cancer[J].International journal of cancer,1998,79(1):34-8.
[15] GHANIPOUR A,JIRSTRöM K,PONTéN F,et al.The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer[J].Cancer epidemiology,biomarkers&prevention:a publication of the American Association for Cancer Research,cosponsored by the American Society of Preventive Oncology,2009,18(11):2949-56.
[16] KUSHNER J P,BOLL D,QUAGLIANA J,et al.Elevated methionine-tRNA synthetase activity in human colon cancer[J].Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine(New York,NY),1976,153(2):273-6.
[17] WANG D,ZHAO R,QU Y Y,et al.Colonic Lysine Homocysteinylation Induced by High-Fat Diet Suppresses DNA Damage Repair[J].Cell reports,2018,25(2):398-412.e6.
[18] PERŁA-KAJáN J,TWARDOWSKI T,JAKUBOWSKI H.Mechanisms of homocysteine toxicity in humans[J].Amino acids,2007,32(4):561-72.
[19] JAKUBOWSKI H,ZHANG L,BARDEGUEZ A,et al.Homocysteine thiolactone and protein homocysteinylation in human endothelial cells:implications for atherosclerosis[J].Circulation research,2000,87(1):45-51.
[20] ZHANG H S,CAO E H,QIN J F.Homocysteine induces cell cycle G1 arrest in endothelial cells through the PI3K/Akt/FOXO signaling pathway[J].Pharmacology,2005,74(2):57-64.
Full Text:
DOI